← Back
Data updated: Mar 10, 2026
SIGMA TAU
OncologyDermatology
SIGMA TAU is a biotechnology company focused on Oncology, Dermatology.
1994
Since
1
Drugs
-
Trials
1
Approved (2yr)
Key Drugs
No active drugs
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 88%
1 drugs Phase 1: 1
Dermatology 13%
0 drugs Phase 1: 1
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 1994-02-01
- Latest
- 2024-03-13
- Applications
- 1